[Methotrexate-induced interstitial pneumonitis in a child with acute lymphoblastic leukemia]

Chiho Tatsumoto1, Kiyoshi Kawakami, Jun Nagayama

  • 1Department of Pediatrics, Kagoshima City Hospital.

Insights

Methotrexate (MTX) can cause interstitial pneumonitis in children with acute lymphoblastic leukemia. This rare complication requires physician awareness during maintenance therapy.

Area of Science:

  • Pediatric Oncology
  • Pulmonology
  • Pharmacology

Background:

  • Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
  • Methotrexate (MTX) is a key chemotherapeutic agent used in ALL treatment.
  • Long-term, low-dose MTX is often employed for maintenance therapy.

Observation:

  • A 5-year-old boy with ALL developed fever, cough, dyspnea, and hypoxemia during MTX maintenance therapy.
  • Clinical, radiological, and laboratory findings supported a diagnosis of MTX-induced interstitial pneumonitis.
  • The patient's condition improved after discontinuing MTX.

Findings:

  • MTX-induced interstitial pneumonitis is a recognized adverse effect, though rarely reported in pediatric leukemia.
  • This case highlights a potential severe pulmonary complication of low-dose MTX in children with ALL.
  • The prevalence in adult rheumatoid arthritis patients is 0.3-7.5%, but data in pediatric leukemia is scarce.

Implications:

  • Physicians must consider MTX pneumonitis in children with ALL presenting with respiratory symptoms during maintenance therapy.
  • Early recognition and MTX cessation are crucial for patient recovery.
  • Further research is needed to understand the incidence and risk factors of MTX pneumonitis in pediatric leukemia.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...